Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rawal, N.
Right arrow Articles by Pangburn, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rawal, N.
Right arrow Articles by Pangburn, M. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 27, 16828-16835, July 3, 1998

C5 Convertase of the Alternative Pathway of Complement
KINETIC ANALYSIS OF THE FREE AND SURFACE-BOUND FORMS OF THE ENZYME

Nenoo Rawal and Michael K. Pangburn

From the Department of Biochemistry, University of Texas Health Science Center, Tyler, Texas 75710

Although proteolytic activation of the complement protein C5 initiates important defensive and occasionally pathological inflammatory reactions, the enzymatic properties of the enzymes responsible for this cleavage have never been examined. We have studied the kinetic parameters of the C5 convertase of the alternative pathway of complement, either bound to a zymosan surface or in its monomeric soluble form. C5 convertase enzymatic activity was measured as a function of C5 concentration by quantitating production of C5b,6 under physiological conditions of temperature, pH, and ionic strength. The C5 convertases appeared to follow Michaelis-Menten kinetics and exhibited similar catalytic rate constants (kcat). However, the surface-bound enzyme, ZymC3b,Bb had a Km (1.4 µM) that was 17 times lower than that of the soluble monomeric form of the enzyme, C3b,Bb (Km = 24 µM). The kcat for the cell-bound enzyme, ZymC3b,Bb was 0.0048 s-1 and that for soluble C3b,Bb was 0.0110 s-1. Both forms of the enzyme had a low turnover number at Vmax (0.23 to 0.68 C5/min/enzyme). Substituting Mg2+ for Ni2+ did not alter the kinetic parameters but lowered the half-life of the enzyme by 5-7-fold. The kinetic data presented demonstrate that the fluid phase C5 convertase, C3b,Bb, can cleave C5 without the aid of a second C3b molecule. The results also show that the greater enzymatic activity previously observed for the surface-bound C5 convertases is not due to higher catalytic efficiency but is solely due to higher affinity for the substrate C5. In blood, C5 concentrations are 3-4-fold below the Km determined for the surface-bound C5 convertase suggesting a direct correlation between the local C5 concentration and production of the anaphylatoxin C5a and the cytolytic C5b-9 complex.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
V. P. Ferreira, A. P. Herbert, C. Cortes, K. A. McKee, B. S. Blaum, S. T. Esswein, D. Uhrin, P. N. Barlow, M. K. Pangburn, and D. Kavanagh
The Binding of Factor H to a Complex of Physiological Polyanions and C3b on Cells Is Impaired in Atypical Hemolytic Uremic Syndrome
J. Immunol., June 1, 2009; 182(11): 7009 - 7018.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. J. Katschke Jr., S. Stawicki, J. Yin, M. Steffek, H. Xi, L. Sturgeon, P. E. Hass, K. M. Loyet, L. DeForge, Y. Wu, et al.
Structural and Functional Analysis of a C3b-specific Antibody That Selectively Inhibits the Alternative Pathway of Complement
J. Biol. Chem., April 17, 2009; 284(16): 10473 - 10479.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Rawal, R. Rajagopalan, and V. P. Salvi
Activation of Complement Component C5: COMPARISON OF C5 CONVERTASES OF THE LECTIN PATHWAY AND THE CLASSICAL PATHWAY OF COMPLEMENT
J. Biol. Chem., March 21, 2008; 283(12): 7853 - 7863.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
I. Jongerius, J. Kohl, M. K. Pandey, M. Ruyken, K. P.M. van Kessel, J. A.G. van Strijp, and S. H.M. Rooijakkers
Staphylococcal complement evasion by various convertase-blocking molecules
J. Exp. Med., October 1, 2007; 204(10): 2461 - 2471.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. A. Figueira, S. Ram, R. Goldstein, D. W. Hood, E. R. Moxon, and S. I. Pelton
Role of Complement in Defense of the Middle Ear Revealed by Restoring the Virulence of Nontypeable Haemophilus influenzae siaB Mutants
Infect. Immun., January 1, 2007; 75(1): 325 - 333.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Garg, P. F. Barnes, A. Porgador, S. Roy, S. Wu, J. S. Nanda, D. E. Griffith, W. M. Girard, N. Rawal, S. Shetty, et al.
Vimentin Expressed on Mycobacterium tuberculosis-Infected Human Monocytes Is Involved in Binding to the NKp46 Receptor
J. Immunol., November 1, 2006; 177(9): 6192 - 6198.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. P. Ferreira, A. P. Herbert, H. G. Hocking, P. N. Barlow, and M. K. Pangburn
Critical Role of the C-Terminal Domains of Factor H in Regulating Complement Activation at Cell Surfaces
J. Immunol., November 1, 2006; 177(9): 6308 - 6316.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Afrimzon, N. Zurgil, Y. Shafran, J. Sandbank, R. Orda, S. Lalchuk, and M. Deutsch
Monitoring of Intracellular Enzyme Kinetic Characteristics of Peripheral Mononuclear Cells in Breast Cancer Patients
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 235 - 241.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. U. Lutz, P. Stammler, V. Bianchi, R. M. Trueb, T. Hunziker, R. Burger, E. Jelezarova, and P. J. Spath
Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level
Blood, January 15, 2004; 103(2): 465 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Rawal and M. K. Pangburn
Formation of High Affinity C5 Convertase of the Classical Pathway of Complement
J. Biol. Chem., October 3, 2003; 278(40): 38476 - 38483.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Rawal and M. K. Pangburn
Formation of High-Affinity C5 Convertases of the Alternative Pathway of Complement
J. Immunol., February 15, 2001; 166(4): 2635 - 2642.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. K. Pangburn, K. L. W. Pangburn, V. Koistinen, S. Meri, and A. K. Sharma
Molecular Mechanisms of Target Recognition in an Innate Immune System: Interactions Among Factor H, C3b, and Target in the Alternative Pathway of Human Complement ,2
J. Immunol., May 1, 2000; 164(9): 4742 - 4751.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Rawal and M. K. Pangburn
Functional Role of the Noncatalytic Subunit of Complement C5 Convertase
J. Immunol., February 1, 2000; 164(3): 1379 - 1385.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement